CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Planned sale CFO and Chief Corp. Dev. Off sold 45,887 shares at $0.90 ($41,147)
- 4 Planned sale Chief Medical Officer sold 45,887 shares at $0.90 ($41,147)
- 4 Insider Changes in Ownership
- 4 Grant or award CFO and Chief Corp. Deve. Off. acquired 311,100 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 311,100 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 2,241,045 shares at an average $1.67 ($3,733,191)
- 4 Open-market sale President, CEO and Director sold 2,241,045 shares at an average $1.67 ($3,733,191)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 12 · 235 filings